Pay in 4 interest-free payments of $5.07 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Fan X, Zhang C, Liu DB, Yan J, Liang HP
They can reduce hepatic steatosis (fat accumulation in the liver), which is a characteristic of non-alcoholic fatty liver disease (NAFLD)
Overall, the findings of this study showed that liraglutide ameliorated OA-associated pain, possess anti-inflammatory and analgesic properties, and could constitute a novel therapeutic candidate for OA treatment
DOI: 10.1016/j.phrs.2022.106257 [Google Scholar] Liu QK
Patients with primary carnitine deficiency display alterations in the renal handling of L-carnitine and/or the transport of the compound into muscle tissue
For parameter estimation, the maximum-likelihood approach is used
US$ 29.81
US$ 21.26
US$ 21.81
US$ 25.62
US$ 27.30
